戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  hybrid lymphocyte that expresses both B and T cell receptors.
2 constant alpha and beta domains of the human T-cell receptor, a technology known as bispecific engage
3 lin BTN3A1 inhibits tumor-reactive alphabeta T cell receptor activation by preventing segregation of
4                        We further found that T cell receptor activation induces the formation of CRAC
5 K) has been shown to play a critical role in T cell receptor activation-induced remodeling of energy
6                      We found that mimicking T-cell receptor activation in Jurkat leukemia cells indu
7 ral TCRs (e.g., immune-mobilizing monoclonal T cell receptors against cancer [ImmTAC] molecules), whe
8                 Immune mobilizing monoclonal T Cell receptors against virus (ImmTAV) molecules repres
9  intra- and inter-method reproducibility for T cell receptor alpha (TRA) and T cell receptor beta (TR
10 e-based single-cell RNA sequencing of paired T cell receptor alpha and beta chain sequences show pron
11 r staining and coexpression of CD161 and the T-cell receptor alpha variable gene TRAV1-2 were strongl
12 ures of immunoglobulin H (IgH), Igkappa, and T cell receptor-alpha (TCRalpha) loci during B lymphopoi
13                            Using single-cell T cell receptor analysis, we provide evidence that neoan
14 iles of immune cells, coupled with assembled T cell receptor and B cell receptor sequences, we analyz
15 pathways affected in these disorders include T cell receptor and B cell receptor signaling, cytokine
16  also identified Epstein-Barr virus-specific T cell receptors and EBV(+) lymphocytes in the affected
17 as a centralized resource for those studying T cell receptors and their recognition.
18    The tyrosine phosphatase PTPN2 attenuates T-cell receptor and cytokine signaling in T cells to mai
19 ing of automatically prepared libraries from T-cell receptor and immunoglobulin gene rearrangements i
20 mple, transcriptional activation of both the T-cell receptor and programmed cell death protein 1 path
21 ive cell therapy, including chimeric antigen T-cell receptors and other novel T-cell receptor-based t
22 nx, but OT1 mice fail to do so because their T cell receptors are engineered to recognize a single ov
23 igands for stimulation and co-stimulation of T-cell receptors are presented via the fluid, synthetic
24 fect phosphorylation of Zap70 (zeta chain of T cell receptor-associated protein kinase 70).
25  family tyrosine kinase (LYN), zeta chain of T-cell receptor-associated protein kinase 70 (ZAP-70), a
26        This study delineated a stromal Lama5-T cell receptor axis that can be targeted for immune tol
27 ric antigen T-cell receptors and other novel T-cell receptor-based therapies.
28 TOF) and next-generation sequencing of B and T cell receptor (BCR and TCR) repertoires, we demonstrat
29  a repository of currently >14 million B and T cell receptor (BCR and TCR) sequences from the blood o
30 ntigen (HLA) receptors as well as B cell and T cell receptors (BCR and TCR).
31 ecific engagement by antibodies based on the T-cell receptor (BEAT).
32 quency, which prompted us to investigate the T cell receptor beta (TCRbeta) repertoire in the CP and
33                  In this study, we performed T cell receptor beta (TCRbeta) sequencing of virus-speci
34 cibility for T cell receptor alpha (TRA) and T cell receptor beta (TRB) TCR chains.
35 anistically, this was a T cell-intrinsic and T cell receptor beta-chain variable-dependent phenomenon
36 k adaptive immunity had no lung disease, and T-cell receptor beta chain (Tcrb)(-/-) STING N153S anima
37 ty of IDH1 mutants to the CDR3 domain of the T-cell receptor beta chain (TRB).
38 cer patients, with a focus on studies of the T-cell receptor beta chain locus.
39         However, common usage or pairings of T-cell receptor beta variable or joining genes, specific
40                               We studied the T-cell receptor beta-chain (TCRbeta) usage and phenotype
41 ssociated with oligoclonality and restricted T-cell receptor beta-chain V-J pairing in CD8(+) but not
42 e class T epitope on SEB overlapped with the T-cell receptor binding site, whereas other evidence sug
43  II complex stability, beta167-169 RGD loop, T-cell receptor binding, formation of homodimer of alpha
44 here ICI are effective, with concomitant low T-cell receptor clonalities.
45                                   By mapping T cell receptor clonality, we find that responding patie
46 l and self-immunopeptidomes and intratumoral T cell receptor clonality.
47 type, transcriptome, epigenetic profile, and T cell receptor clonotype, the authors provide evidence
48 r and regulatory T-cell subsets with diverse T-cell receptor clonotypes in the periphery.
49         Thymus structure, immunophenotyping, T-cell receptor clonotypes, T-cell function, immune resp
50  around anchor pockets 1 and 9, as potential T-cell receptor contacts, in the areas for CD4 binding a
51 +) T cell differentiation by ensuring normal T cell receptor density and signaling.
52  least 91 unique clones expressing different T-cell receptors) directed against HLA*02:01-restricted
53                                Additionally, T-cell receptor diversity, cytolytic activity score (CYT
54 getic and biosynthetic programs and licences T cell receptor driven proteome reprogramming.
55 the multi-phenotypic impact of disrupting 25 T cell receptor-driven kinases.
56 nical benefit demonstrated overexpression of T cell receptor-encoding genes.
57 avior in mice and was partially dependent on T cell receptor engagement and commensal-derived signals
58 tched, control C57BL/6 mouse LNSC suppressed T-cell receptor engagement by anti-CD3/CD28 via MHC-inde
59                         Adoptive transfer of T cell receptor-engineered (TCR-engineered) T cells is a
60 a recombinant CHIKV strain encoding a CD8(+) T cell receptor epitope from ovalbumin, as well as a vir
61 r severe combined immunodeficiency using the T-cell receptor excision circle assay.
62                                 Infants with T-cell receptor excision circle values of less than a de
63 owed TCR V-beta repertoire usage and diluted T-cell receptor excision circles confirm that DN T cells
64 ly arises from a small subset of gamma/delta T-cell receptor-expressing lymphocytes.
65  CD8+ Tem and Temra cells showed some unique T cell receptor features in terms of overlap and variabl
66                         Here, we report that T cell receptor fusion constructs (TRuCs) comprising an
67 ficile infection showed increased IL-17A and T cell receptor gamma chain expression, and IL-17 produc
68 e, but molecular testing identified the same T-cell receptor gamma rearrangement present in the gastr
69         Molecular analysis revealed a clonal T-cell receptor gamma rearrangement.
70  functional avidity of selected gamma9delta2 T cell receptors (gamma9delta2TCRs), was not associated
71 merase chain reaction-based investigation of T-cell receptor gene rearrangement to detect clonality.
72 ntitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements.
73 cell clones through paired sequencing of the T cell receptor genes and high-dimensional single-cell s
74 combination assembles and diversifies Ig and T cell receptor genes in developing B and T lymphocytes.
75 Furthermore, we isolated a number of cognate T cell receptor genes with tumor reactivity.
76 ulation critically enhanced signaling by the T cell receptor in the formation of functional immune sy
77                        Crystal structures of T cell receptors in complex with HLA-DQ2.5 bound to two
78 rming deep single-cell sequencing of RNA and T cell receptors in patients with different types of can
79 ofiles of various populations of T cells and T cell receptors in tumours, normal adjacent tissue, and
80                    Signals downstream of the T cell receptor influence whether individual clones bear
81 rate to the thymus to give rise to embryonic T cell receptor-invariant T cells.
82   The effectiveness of pathogen detection by T cell receptor is limited by chemical similarity of for
83  the antigenic specificity of the gammadelta T cell receptors is incompletely understood.
84 to reach the stationary concentration of the T-cell-receptor-ligand-activated complex, which transfer
85 on of a network of inhibitory and activating T cell receptors may be a critical step in the developme
86  and fatty acid oxidation, without affecting T cell receptor-mediated activation.
87 ory triggers that can enhance or even bypass T cell receptor-mediated signals-substantially broadenin
88 synapse is classically described between the T-cell receptor of CD4-positive lymphocytes and MHC II o
89 d presentation of a resulting peptide to the T cell receptor on classical peptide-recognizing CD4(+)
90                           As well as binding T cell receptors on CD8(+) T cells, HLA class I molecule
91 lls coengineered with a Fas DNR and either a T cell receptor or chimeric antigen receptor exhibited e
92  of activation mediated by engagement of the T-cell receptor or of CD16.
93                                              T cell receptor phosphorylation by Lck is an essential s
94                Our theoretical method models T cell receptor phosphorylation events as a sequence of
95 g thymocyte development, requires myriad pre-T cell receptors (preTCRs) and alphabetaTCRs.
96 on of T cells, measured through increases of T-cell receptor productive frequencies, mirrored ctDNA r
97 onse, profound immune exhaustion with skewed T cell receptor repertoire and broad T cell expansion.
98 ed self-antigen representation and increased T cell receptor repertoire diversity.
99 includes critical variables, such as MHC and T cell receptor repertoire, is needed.
100           We identified a highly oligoclonal T cell receptor repertoire, which we localized to activa
101 T cell neogenesis and diversification of the T cell receptor repertoire.
102                                              T-cell receptor repertoire analyses showed similar clona
103  (UC) using single-cell transcriptomics with T-cell receptor repertoire analysis and mass cytometry.
104                                              T-cell receptor repertoire analysis, flow cytometry, mul
105                             We evaluated the T-cell receptor repertoire associated with 72 primary Me
106 ell carcinomas and correlated metrics of the T-cell receptor repertoire with clinicopathologic charac
107  immune-monitoring reveals remodeling of the T-cell receptor repertoire with immunodominant clones an
108 transport into the endoplasmic reticulum and T-cell receptor repertoire, also contribute to the immun
109 ubsets and systemic remodeling of peripheral T cell receptor repertoires.
110 d ability to induce c-Jun/AP-1 expression on T cell receptor restimulation, a mechanism that may cont
111 ate-like T cells expressing a semi-invariant T cell receptor restricted to the non-classical MHC clas
112                                              T cell receptor sequence comparison between patients ide
113 matical modeling and statistical analyses of T cell receptor sequencing data, we develop a quantitati
114                                              T cell receptor sequencing monitored repertoires during
115  enrichment of immune-related processes, and T cell receptor sequencing revealed increased clonality
116                RNase H-dependent PCR-enabled T-cell receptor sequencing (rhTCRseq) can be used to det
117  tumors, we conducted whole genome, RNA, and T-cell receptor sequencing, immunohistochemistry and rev
118 solve the spatial and temporal resolution of T cell receptor signaling in the context of immune respo
119 ever, the relative contributions of IL-2 and T cell receptor signaling to this process are unknown.
120  tyrosine phosphosites that mediate proximal T cell receptor signaling, cytoskeletal organization, an
121 Here, we review the current understanding of T-cell receptor signaling and their intersection with IC
122  TNFalpha (tumor necrosis factor-alpha), and T-cell receptor signaling pathways, cytokines involved i
123 cts, including posttranscription regulation, T-cell receptor signaling, and metabolic function.
124  3-kinase/AKT/mTOR activation independent of T-cell receptor signaling.
125 h CD8 T cells engineered to express anti-SIV T-cell receptor specificities enables direct experimenta
126 hibiting T cell proliferation in response to T cell receptor stimulation and mediating fibroblast cel
127       Expression of TOX is driven by chronic T cell receptor stimulation and NFAT activation.
128                                              T cell receptor stimulation induces depletion of the end
129 s in TILs was induced by the coordination of T cell receptor stimulation, microenvironmental stressor
130 vels of peripheral blood engraftment with E6 T-cell receptor T cells 1 month after treatment (median,
131 thermore, we were able to isolate and verify T cell receptors targeting KRASG12D mutation.
132                                              T cell receptor (TCR) activation is modulated by mechani
133 amily kinases (pSFK), LAT and PLC-gamma over T cell receptor (TCR) alone.
134         CD8alphabeta is a coreceptor for the T cell receptor (TCR) and binds to the same cognate pMHC
135  analyzing the cytokine production following T cell receptor (TCR) and co-receptor stimulation with a
136 perior antitumor reactivity, we isolated the T cell receptor (TCR) and demonstrated specific recognit
137 es through concomitant crosslinking of their T cell receptor (TCR) and FcgammaRI.
138                              The assembly of T cell receptor (TCR) and immunoglobulin (Ig) genes by V
139 immune tolerance whose activity depends upon T cell receptor (TCR) and mTORC1 kinase signaling, but t
140  four previously described Valpha3.2 Vbeta14 T cell receptor (TCR) cDNAs, the dominant clonotype gene
141            Two genes encoding the endogenous T cell receptor (TCR) chains, TCRalpha (TRAC) and TCRbet
142 hat a subpopulation of T cells expresses two T cell receptor (TCR) clonotypes, though the extent and
143               Crystal structures of the MAIT T cell receptor (TCR) complexed with MR1-DB28 and MR1-NV
144                                We found that T cell receptor (TCR) engagement induces the selective p
145 itive selection in the thymus when their new T cell receptor (TCR) engages and signals in response to
146                         However, the role of T cell receptor (TCR) in this process remains unclear.
147                                          The T cell receptor (TCR) initiates the elimination of patho
148 T cell maturation and activation depend upon T cell receptor (TCR) interactions with a wide variety o
149        Mechanosensing by T cells through the T cell receptor (TCR) is at the heart of immune recognit
150 imeric antigen receptor (CAR) or a classical T cell receptor (TCR) is revolutionizing cancer treatmen
151  Moreover, neoantigen-reactive T cells and a T cell receptor (TCR) isolated from the CD8+PD-1+ subset
152                                              T cell receptor (TCR) ligand discovery is crucial to mon
153                                              T cell receptor (TCR) ligand discovery is essential for
154 nds whether they represent direct gammadelta T cell receptor (TCR) ligands.
155  cells engineered to express an HBV-specific T cell receptor (TCR) may achieve cure of HBV infection
156 gy to study OT-1 T cells, revealing that the T cell receptor (TCR) mechanically samples antigens carr
157                                            A T cell receptor (TCR) mediates antigen-induced signaling
158 l-mediated immunity is governed primarily by T cell receptor (TCR) recognition of peptide-human leuko
159 de CRISPR-Cas9 screening to establish that a T cell receptor (TCR) recognized and killed most human c
160 ruct T cell differentiation trajectories and T cell receptor (TCR) recombination kinetics.
161 r TILs, TSA-reactive TILs possess a distinct T cell receptor (TCR) repertoire and unique gene feature
162 respond to nickel but the involved alphabeta T cell receptor (TCR) repertoire has not been comprehens
163                               Monitoring the T cell receptor (TCR) repertoire in health and disease c
164                                          The T cell receptor (TCR) repertoire is diverse, thus allowi
165 of mice and humans we demonstrate that their T cell receptor (TCR) repertoire is highly diverse and i
166 y, but its influence on the antigen-specific T cell receptor (TCR) repertoire is unknown.
167                                The alphabeta T cell receptor (TCR) repertoire on mature T cells is se
168 ported by a combination of immunophenotypic, T cell receptor (TCR) repertoire, functional, and transc
169  multifaceted impact on the exhausted CD8(+) T cell receptor (TCR) repertoire.
170 +)CD4(+) conventional T cells with a diverse T cell receptor (TCR) repertoire.
171 s, leading to a detrimental reduction of the T cell receptor (TCR) repertoire.
172 t peptidome variation contributes to shaping T cell receptor (TCR) repertoires and hence individual i
173                    B cell receptor (BCR) and T cell receptor (TCR) repertoires are generated through
174 ation of commonalities and differences among T cell receptor (TCR) repertoires from different individ
175                                 The study of T cell receptor (TCR) repertoires has generated new insi
176 els parameterized by deep neural networks to T cell receptor (TCR) repertoires.
177                            Activation of the T cell receptor (TCR) results in binding of the adapter
178 clude selecting an appropriate repertoire of T cell receptor (TCR) self-affinities in the thymus, reg
179                                              T cell receptor (TCR) sequence analysis demonstrated tha
180 tigens, T cells generate a vast diversity of T cell receptor (TCR) sequences.
181  We utilized the complementary approaches of T cell receptor (TCR) sequencing and cytometry by time-o
182 ere assessed with single-cell RNA and paired T cell receptor (TCR) sequencing of 30,604 T cells from
183 Herein, we perform genome-wide DNA, RNA, and T cell receptor (TCR) sequencing on 29 cutaneous gammade
184       Transcriptional profiling coupled with T cell receptor (TCR) sequencing reveal lineage connecti
185 In this issue of the JCI, Ogongo et al. used T cell receptor (TCR) sequencing to characterize unconve
186                                     Both the T cell receptor (TCR) signal and environmental cues cont
187 ntified an interaction between Trib1 and the T cell receptor (TCR) signaling activator, MALT1, which
188 T cells through the phosphatase SHP1 reduced T cell receptor (TCR) signaling and preformed CD40 ligan
189     It is known that antigen recognition and T cell receptor (TCR) signaling depend on forces applied
190 sphorylating substrates involved in proximal T cell receptor (TCR) signaling.
191 theta) is an important component of proximal T cell receptor (TCR) signaling.
192 re, single-cell RNA sequencing revealed that T cell receptor (TCR) signalling was enhanced in these c
193         Naive CD4(+) T cells experience weak T cell receptor (TCR) signals induced by self-peptides p
194 ity in BDC2.5XNOD mice carrying a transgenic T cell receptor (TCR) specific for a beta cell autoantig
195 nt cardiac autoantigen and that T cells with T cell receptor (TCR) specificity to MYHCA acquired a Tr
196                                              T cell receptor (TCR) stimulation activates diverse kina
197     Moreover, NKT2 cells receive and require T cell receptor (TCR) stimulation for continuous IL-4 pr
198 arker up-regulation, and proliferation after T cell receptor (TCR) stimulation.
199 ng an antibody-based binding domain fused to T cell receptor (TCR) subunits can effectively reprogram
200 ted by signaling molecules downstream of the T cell receptor (TCR) that are organized by adaptor prot
201                                              T cell receptor (TCR) transductants and BTN3-deficient h
202             In marked contrast to the biased T cell receptor (TCR) usage associated with HLA-DQ2.5-me
203 (SEB), which naturally links a proportion of T cell receptor (TCR) Vbeta subtypes to MHC-II, present
204 integrates signal strength downstream of the T cell receptor (TCR) within activated thymocytes and pe
205 l, we report that, similar to the endogenous T cell receptor (TCR), antigen engagement triggers the f
206                                          The T cell receptor (TCR)-CD3 complex comprises a diverse al
207 ule Qa-1, which disrupts Qa-1 binding to the T cell receptor (TCR)-CD8 complex and impairs the CD8 Tr
208 mmadelta T cell population that respond in a T cell receptor (TCR)-dependent manner to phosphoantigen
209 pivotal regulators of immune tolerance, with T cell receptor (TCR)-driven activated T reg (aT reg) ce
210 t are based on vaccination or on infusion of T cell receptor (TCR)-engineered T cells.
211 dozens of unique barcoded templates into the T cell receptor (TCR)-locus revealed gene constructs tha
212 e.g., virus-infected cells, which depends on T cell receptor (TCR)-mediated activation of beta(2)-int
213                                          The T cell receptor (TCR)-peptide-MHC (pMHC) interaction is
214                       Adoptively transferred T cell receptor (TCR)-transgenic T cells (TCR-T cells) a
215 ellular interactions with the Vgamma9Vdelta2 T cell receptor (TCR).
216 ll related to the chains that constitute the T cell receptor (TCR).
217 e different ligand binding half-lives to the T cell receptor (TCR).
218 erized, in part, by the TRAV1-2(+) alphabeta T cell receptor (TCR).
219 nising MHC-related protein-1 (MR1) via their T cell receptor (TCR).
220  molecular modeling, we established that the T cell receptor (TCR):CD3 complex is required for USSN-i
221 on concurrent signaling by Notch and the pre-T cell receptor (TCR); however, it is unclear how these
222 ineering chimeric antigen receptors (CAR) or T cell receptors (TCR) helps create disease-specific T c
223 l neoantigens featuring an oligo-/monoclonal T cell-receptor (TCR) repertoire.
224 veloping biomarkers based on analysis of the T-cell receptor (TCR) alpha repertoire to assist in the
225               We studied an insulin-reactive T-cell receptor (TCR) alpha-chain transgenic NOD mouse o
226 iciencies received 155 mismatched grafts: 30 T-cell receptor (TCR) alphabeta/CD19-depleted grafts, 43
227 tivation by enabling interaction between the T-cell receptor (TCR) and human leukocyte antigen class
228              Virtually all T-PLL expressed a T-cell receptor (TCR) and/or CD28-coreceptor without ove
229 omote activation of T cells by strengthening T-cell receptor (TCR) binding to cognate peptide-MHC com
230 ) can be used to determine paired alpha/beta T-cell receptor (TCR) clonotypes in single cells or perf
231 (9-23)) specificity, and mutation of the key T-cell receptor (TCR) contact residue within the epitope
232  peptide elution, mixed lymphocyte reaction, T-cell receptor (TCR) deep sequencing, tetramer-guided n
233 y and clonality index of T cells by means of T-cell receptor (TCR) immunosequencing in a discovery da
234              Knockout (KO) of the endogenous T-cell receptor (TCR) in CD19-CAR-T cells may be a promi
235 e clone size distribution of the human naive T-cell receptor (TCR) repertoire is an important determi
236                 We performed whole-exome and T-cell receptor (TCR) repertoire sequencing on multi-reg
237 vC2-V5 single-genome amplification (SGA) and T-cell receptor (TCR) repertoires assessed.
238                             The diversity of T-cell receptor (TCR) repertoires is achieved by a combi
239 udy, we developed statistical classifiers of T-cell receptor (TCR) repertoires that distinguish tumor
240 with a substantial increase in the number of T-cell receptor (TCR) sequences and their cognate antige
241                                          Pre-T-cell receptor (TCR) signal transduction is required fo
242                            The suppressor of T-cell receptor (TCR) signaling (Sts) proteins Sts-1 and
243                                              T-cell receptor (TCR) signaling strength is a dominant f
244              To determine how LAIR-1 affects T-cell receptor (TCR) signaling, we compared 1) T cells
245 ine residues in response to Listeria-induced T-cell receptor (TCR) stimulation in both naive and memo
246 d tissue and generated an affinity-optimized T-cell receptor (TCR) with specificity to AFP/HLA-A*02(+
247 or a range of immunoreceptors, including the T-cell receptor (TCR), and show that this generic ligand
248 ng through multiple receptors, including the T-cell receptor (TCR), co-receptors, and cytokine recept
249 ructural determinants with those utilized by T-cell receptor (TCR), killer-cell immunoglobulin-like r
250 potent antigens in vivo despite their strong T-cell receptor (TCR)-binding affinities.
251                                          The T-cell receptor (TCR)-CD3 complex is composed of a diver
252 d in many immune responses, mediated through T-cell receptor (TCR)-dependent and/or independent activ
253                                              T-cell receptor (TCR)beta screening showed tremelimumab
254                                              T-cell receptors (TCR) have considerable potential as th
255                    The diverse repertoire of T-cell receptors (TCR) plays a key role in the adaptive
256                            The regulation of T cell receptor Tcra gene rearrangement has been extensi
257 n the binding of pathogenic superantigens to T cell receptors (TCRs) and/or major histocompatibility
258                                              T cell receptors (TCRs) are critical molecules of the ad
259 cells engineered to express antigen-specific T cell receptors (TCRs) are potent therapies for viral i
260                                  Recombinant T cell receptors (TCRs) can be used to redirect naive T
261 can correctly identifies cognate antigens of T cell receptors (TCRs) from viral and human genome-wide
262 histocompatibility complex (pMHC) ligand for T cell receptors (TCRs) is inactive from solution yet ca
263                                         Four T cell receptors (TCRs) made up the TIL infusion and rec
264 ntiation (CD)8(+) T cells, by means of their T cell receptors (TCRs) recognizing intracellular target
265 cocultured T cells expressing MCPyV-specific T cell receptors (TCRs) show increased cytokine producti
266 e of Vdelta1, three CD1b-specific gammadelta T cell receptors (TCRs) showed clear differences in the
267                   T cells express clonotypic T cell receptors (TCRs) that recognize peptide antigens
268  threats in an antigen-specific manner using T cell receptors (TCRs) that recognize short peptide ant
269 e distinctive nature of DURTs and gammadelta T cell receptors (TCRs) to investigate the involvement o
270                               The binding of T cell receptors (TCRs) to their target peptide MHC (pMH
271     High-avidity CBFB-MYH11 epitope-specific T cell receptors (TCRs) transduced into CD8+ T cells con
272                  Studying the composition of T cell receptors (TCRs) using next-generation sequencing
273 eron-gamma-producing Vdelta1(+) IELs bearing T cell receptors (TCRs) with a shared non-germline-encod
274 ng the associations of particular gammadelta T cell receptors (TCRs) with specific anatomical sites.
275  on other cells, much like MHC molecules and T cell receptors (TCRs).
276                                              T-cell receptors (TCRs) are immune proteins that primari
277 their signature feature, the clonal-specific T-cell receptors (TCRs) for antigen.
278                      The interaction between T-cell receptors (TCRs) of T-cells and potentially immun
279                                              T-cell receptors (TCRs) recognize pathogens to ignite im
280                       We studied oligoclonal T-cell receptors (TCRs) that recognize a shared neoepito
281 sly described GLIPH, an algorithm to cluster T-cell receptors (TCRs) that recognize the same epitope
282                            T cells use their T-cell receptors (TCRs) to scan other cells for antigeni
283 gineered T cells expressing antigen-specific T-cell receptors (TCRs), is an appealing therapeutic app
284 i-CD1d antibodies that block CD1d binding to T-cell receptors (TCRs).
285 ough bivalent engagement and dimerization of T-cell receptors (TCRs).
286 ce is influenced by clonotypically expressed T-cell receptors (TCRs).
287               Neonatal thymocytes expressing T cell receptors that engage IA(b)-Padi4 with moderate d
288 ex (MHC) class I, MHC class II and alphabeta T cell receptors, the antigenic specificity of the gamma
289             For immunology, the binding of a T cell receptor to an antigen-presenting pMHC initiates
290 oteins interact to transmit signals from the T-cell receptor to the nucleus.
291 c variability of the immunoglobulin (Ig) and T cell receptor (TR) gene loci.
292 ribe a variant of spontaneous EAE in the 2D2 T cell receptor transgenic mouse (2D2(+) mouse) that pre
293                               Using a CD8(+) T-cell receptor transgenic model, we show that the CXCL1
294 al of GBM-bearing mice in both syngeneic and T-cell receptor transgenic models.
295                                              T-cell receptor transgenic TEa CD4 cells that recognized
296 trate rigidity, implying that early steps in T cell receptor triggering are not mechanosensitive.
297           To address this, sequencing of the T-cell receptor variable-region beta-chain was performed
298 ransmit signals akin to those from activated T-cell receptors when bound to a cell surface target.
299 enes such as IFNA, MRC1, immunoglobulins and T-cell receptors which contribute to defend against path
300 utic strategy combining an affinity-enhanced T Cell receptor with an anti-CD3 T Cell-activating moiet

 
Page Top